Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Osmotica Pharmaceutical

Osmotica Pharmaceutical
1986 FOUNDED
PUBLIC STATUS
401-500 EMPLOYEES
OSMT STOCK SYMBOL
1 INVESTMENTS
$3.29 SHARE PRICE (As of Friday Closing)
Description

Osmotica Pharmaceuticals PLC is a fully-integrated biopharmaceutical company. It is focused on developing, manufacturing and commercializing specialty products. The product portfolio of the group includes specialty neurology and women's health products, which are primarily complex formulations of generic drugs.

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 895 Sawyer Road
  • Marietta, GA 30062
  • United States

+1 (770) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Osmotica Pharmaceutical’s full profile, request a free trial.

Osmotica Pharmaceutical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.20 - $9.90 $173M $3.33 -$2.08 192K 52.5M

Osmotica Pharmaceutical Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 387,068 692,965
Revenue 261,027 263,701 245,749 218,460
EBITDA (20,703) (16,301) (10,140) (8,295)
Net Income (110,989) (109,396) (41,142) (41,821)
Total Assets 776,147 795,645 919,740 978,500
Total Debt 268,119 268,834 320,686 329,025
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Osmotica Pharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Osmotica Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Osmotica Pharmaceutical Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
000000 000000 0000 Corporation Toronto, Canada 00 0000000000
000 000000000 Private Equity-Backed Mumbai, India 000 000.00 0000000 0000 000.00
00000000 000000 Corporate Backed or Acquired Tokyo, Japan 00000 000000000000
0000000000 0000000 Private Equity-Backed Sarasota, FL 00 000000000000
To view this company’s complete list of competitors, request access »

Osmotica Pharmaceutical Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 01-Jan-2017 000000000000000000 000.00 Drug Discovery 00000 00000000
To view this company’s complete investment and acquisition history, request access »

Osmotica Pharmaceutical Executive Team (4)

Name Title Board
Seat
Contact
Info
Andrew Einhorn Chief Financial Officer
Brian Markison Chief Executive Officer

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »